Aphelion Capital invests in medical technology companies, both publicly and privately. By utilizing their extensive understanding of the industry and vast networks, they strive to maximize returns for themselves and the entrepreneurs involved in their investments. Aphelion generally takes a long-term approach with companies they deem to have exceptional products and capable management teams.
26
Total Investments
18
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Aphelion Capital
Recent Investments (26)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Apr 2025 | |
| Late Vc | •••••• | Apr 2024 | |
| Series D | •••••• | Mar 2024 | |
| Series A | •••••• | Jul 2022 | |
| Series B | •••••• | Jun 2022 | |
|
|
Venture Round | •••••• | Apr 2021 |
|
|
Series B | •••••• | Jan 2021 |
|
|
Series A | •••••• | Jan 2021 |
|
|
Late Vc | •••••• | Dec 2020 |
|
|
Series A | •••••• | Jul 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.